Anti-RNLS/ C10orf59/ RENALASE functional antibody

Anti-RNLS/ C10orf59/ RENALASE functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to RNLS/RNLS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1252-Ab-1/ GM-Tg-hg-SE1252-Ab-2Anti-Human RNLS monoclonal antibodyHuman
GM-Tg-rg-SE1252-Ab-1/ GM-Tg-rg-SE1252-Ab-2Anti-Rat RNLS monoclonal antibodyRat
GM-Tg-mg-SE1252-Ab-1/ GM-Tg-mg-SE1252-Ab-2Anti-Mouse RNLS monoclonal antibodyMouse
GM-Tg-cynog-SE1252-Ab-1/ GM-Tg-cynog-SE1252-Ab-2Anti-Cynomolgus/ Rhesus macaque RNLS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1252-Ab-1/ GM-Tg-felg-SE1252-Ab-2Anti-Feline RNLS monoclonal antibodyFeline
GM-Tg-cang-SE1252-Ab-1/ GM-Tg-cang-SE1252-Ab-2Anti-Canine RNLS monoclonal antibodyCanine
GM-Tg-bovg-SE1252-Ab-1/ GM-Tg-bovg-SE1252-Ab-2Anti-Bovine RNLS monoclonal antibodyBovine
GM-Tg-equg-SE1252-Ab-1/ GM-Tg-equg-SE1252-Ab-2Anti-Equine RNLS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1252-Ab-1/ GM-Tg-hg-SE1252-Ab-2; GM-Tg-rg-SE1252-Ab-1/ GM-Tg-rg-SE1252-Ab-2;
GM-Tg-mg-SE1252-Ab-1/ GM-Tg-mg-SE1252-Ab-2; GM-Tg-cynog-SE1252-Ab-1/ GM-Tg-cynog-SE1252-Ab-2;
GM-Tg-felg-SE1252-Ab-1/ GM-Tg-felg-SE1252-Ab-2; GM-Tg-cang-SE1252-Ab-1/ GM-Tg-cang-SE1252-Ab-2;
GM-Tg-bovg-SE1252-Ab-1/ GM-Tg-bovg-SE1252-Ab-2; GM-Tg-equg-SE1252-Ab-1/ GM-Tg-equg-SE1252-Ab-2
Products NameAnti-RNLS monoclonal antibody
Formatmab
Target NameRNLS
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-RNLS benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1252-Ag-1Recombinant multi-species RNLS/ C10orf59/ RENALASE protein
    ORF Viral VectorpGMLP002259human RNLS Lentivirus plasmid
    ORF Viral VectorvGMLP002259human RNLS Lentivirus particle
    ORF Viral VectorpGMLPm002145mouse Rnls Lentivirus plasmid
    ORF Viral VectorvGMLPm002145mouse Rnls Lentivirus particle


    Target information

    Target IDGM-SE1252
    Target NameRNLS
    Gene ID55328,361751,708585,610448,101098402,534778,100062318
    Gene Symbol and SynonymsC10orf59,RENALASE,RGD1309804,RNLS
    Uniprot AccessionQ5VYX0,Q5U2W9
    Uniprot Entry NameRNLS_HUMAN,RNLS_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000184719
    Target ClassificationN/A

    The target: RNLS, gene name: RNLS, also named as C10orf59, RENALASE. Renalase is a flavin adenine dinucleotide-dependent amine oxidase that is secreted into the blood from the kidney (Xu et al., 2005 [PubMed 15841207]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.